Connect Sign In
Mast cell disorders are a diverse group of conditions characterized by inappropriate mast cell activation and/or the proliferation and accumulation of abnormal mast cell
Andrew Fletcher, MD, MBA, CPE, CHCQM, FCAP, medical director of Consultative Services at ARUP, has coauthored a study that shows clinicians frequently do not adhere to clinical guidelines.
David Hillyard, MD, ARUP medical director for molecular infectious disease, is among 20 individuals and organizations honored by Utah Business magazine with a Healthcare Hero Award.
Before the pandemic, telemedicine accounted for less than 1% of all physician visits, but that number spiked to over 50% after the appearance of COVID-19 cases in the United States.
The COVID-19 pandemic has forced laboratories to adapt to an ever-shifting landscape that has challenged many foundational practices for laboratory management.
Perhaps more than ever before, ARUP Blood Services is relying on high school students to help save lives through blood donations, as its usual donor sources have diminished.
A new structure is slowly rising to distinguish the core of University of Utah Research Park. By mid-2021, the building will be the state-of-the-art epicenter of ARUP’s growing operations.
ARUP Laboratories now offers testing to detect the virus that causes COVID-19 using saliva specimens. The molecular diagnostic test is available with preapproval to ARUP clients nationwide.
As a national EAP program to deliver COVID-19 convalescent plasma to hospitalized patients with COVID-19 concludes, researchers are transitioning to multicenter randomized clinical trials.
Telemedicine has become a necessity during the COVID-19 pandemic, and hospital laboratories need to be prepared to modify their operations to accommodate this new mode of delivering healthcare.
The American Society for Clinical Pathology (ASCP) has recognized two ARUP Laboratories employees through its annual 40 Under Forty Program.
When supplies of a critical component of kits used to collect specimens for COVID-19 testing suddenly grew scarce, scientists at ARUP worked to formulate an alternative.
